It's a refactor of QueryWise (a full-stack text-to-SQL app) into a headless tool: no web UI, no Postgres requirement. The metadata store is an embedded SQLite + sqlite-vec database, so the server runs ...
In this post, we will show you how to create email templates in the new Outlook app for Windows 11. Creating email or message templates in Microsoft Outlook (classic) involved manually composing an ...
Data centers have been on the receiving end of increasing public scrutiny, with moratoriums and local protests calling attention to water shortages, higher electricity prices, and deteriorating air ...
The vast data centers that power artificial intelligence guzzle huge amounts of energy but they also have another alarming impact, according to new research. They are creating “heat islands,” warming ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...
The mammoth Project Jupiter data centers complex being constructed for Oracle Corp., in the Santa Teresa, New Mexico area, on El Paso's west edge, is to generate more power than El Paso Electric’s ...
Atlas Compute has proposed a dual data center and power plant in St. Lucie County. The data center is planned to be running by 2027. Atlas Compute, however, has yet to apply for any county approvals.
As seen on diginomica passim, the music industry has a complicated relationship with data and AI. While there’s justifiable concern that emerging technology can be used to shortcut the creative ...
COLUMBUS, Ohio—State officials’ approval of a $4.5 million tax break for a Northeast Ohio data‑center expansion was met with a chorus of online criticism, given that the project will only create 10 ...
Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results